The leukocyte differentiation antigen, CDS0, has been recently identified as the intercellular adhesion molecule 3 (ICAM-3), the third counter-receptor oflenkocyte function-associated antigen 1 (LFA-1). This molecule seems to be specially involved in the adhesion events of the initial phases of the immune response. To characterize the role of CD50 in leukocyte interactions, the different molecular events induced after cross-linking of CDS0 on T cell-derived Jurkat cell line have been analyzed. When cells were incubated with anti-CDS0 mAbs and cross-linked with polyclonal goat anti-mouse immunoglobulins, a rise in intracellular calcium concentration ([CaZ+]i) was observed. This increase in [Ca2+]i was mainly due to the uptake of extracellular C# + . This Ca 2+ flux involved tyrosine phosphorylations and was further increased by CD3 costimulation. These data, together with those obtained by phosphotyrosine (P-Tyr) immunoprecipitation and in vitro kinase assays, suggested the involvement of protein-tyrosine kinases (PTK) in CD50 transduction pathways. By using specific antisera, the presence of p56 ld' and p59 ryn protein tyrosine kinases (FTK) was dearly demonstrated in the CD50 immunoprecipitates. These findings suggest that the interaction of CD50 with its natural ligand (LFA-1) may result in T lymphocyte activation events, in which CDS0 could play a very active role after antigen triggering. T he immune system, composed of redrculating cells, uses a dynamic and complex group of membrane molecules involved in cell-cell interaction mechanisms that are related at different degrees to antigen-dependent proliferation (1). These intercellular interactions are also especially relevant in several steps of inflammatory and immune responses. Among these steps, functions such as lymphocyte traffic between lymphoid organs and the bloodstream, lymphocyte migration to sites of injury, and antigen recognition are to be included (2). Intercellular adhesion is mediated by many different molecules, CD50 being a molecule that plays a prominent role in cell adhesiveness. This molecule has recently been identified by us as intercellular adhesion molecule 3 (ICAM-3) t (3), and it has been described as the third counter-receptor for the leukocyte integrin leukocyte function-associated antigen 1 Abbreviations used in thlspaper: [Ca2+]i, ititracellular calcium concentration; GAM, goat anti-mouse immunoglobulins; ICAM, intercellular adhesion molecule; IP3, D-myo-inositol 1,4,5,-trisphosphate; LFA-1, leukocyte-associated antigen 1; PKC, protein kinase C; PTK, protein tyrosine kinase.
T
he immune system, composed of redrculating cells, uses a dynamic and complex group of membrane molecules involved in cell-cell interaction mechanisms that are related at different degrees to antigen-dependent proliferation (1) . These intercellular interactions are also especially relevant in several steps of inflammatory and immune responses. Among these steps, functions such as lymphocyte traffic between lymphoid organs and the bloodstream, lymphocyte migration to sites of injury, and antigen recognition are to be included (2) . Intercellular adhesion is mediated by many different molecules, CD50 being a molecule that plays a prominent role in cell adhesiveness. This molecule has recently been identified by us as intercellular adhesion molecule 3 (ICAM-3) t (3), and it has been described as the third counter-receptor for the leukocyte integrin leukocyte function-associated antigen 1 Abbreviations used in thlspaper: [Ca2+] i, ititracellular calcium concentration; GAM, goat anti-mouse immunoglobulins; ICAM, intercellular adhesion molecule; IP3, D-myo-inositol 1,4,5,-trisphosphate; LFA-1, leukocyte-associated antigen 1; PKC, protein kinase C; PTK, protein tyrosine kinase. 1 (LFA-1) (4, 5) . Moreover, CD50 seems to be a relevant molecule involved in leukocyte interactions (5, 6) .
CD50 (ICAM-3) was described as a 120-kD, highly expressed, and hematopoietically restricted leukocyte surface antigen during the IV International Workshop on Human Leukocyte Differentiation Antigens (7), being originally defined by two mAbs (101-1D2 and 140-11) that were produced and characterized in our laboratory. The initial description of CD50 mAbs inhibiting allorecognition (6) suggested that CD50 could be a relevant molecule involved in leukocyte interactions. The finding that CD50 became rapidly and transiently phosphorylated on serine residues (8) upon stimulation either by PMA or T cell receptor cross-linking suggested a biochemical regulation of its function. The analysis of CD50 eDNA clones (9) (10) (11) showed the highest homology with ICAM-1 and ICAM-2, especially in their extracellular domains. However, comparison of the intracellular regions showed a low similarity, suggesting a different function for the intracytoplasmic domain of each different ICAM molecule (9, 11) . Indeed, five serine residues in CDS0 cytoplasmic region are, probably, the residues that become phosphorylated in CD50 molecule after protein kinase C (PKC) stimulation induced by PMA or CD3 (8) . This phosphorylation could be a way of controlling a possible CD50 function, such as the LFA-1 phosphorylation in response to phorbol ester (12) . Unlike its homologous ICAM-1 and ICAM-2, this new member of the Ig gene superfamily is highly expressed on resting lymphocytes. This fact strongly suggested that CD50 is preferentially used by lymphocytes in the LFA-l-mediated binding during the initial interactions of immune recognition and lymphocyte activation (5, 9) . Furthermore, its lack of expression in endothelial cells (9, 10) leads us to assume that its possible role in the leukocyte-endothelial cell is indirect.
It has been repeatedly described that, in the ICAM-1/LFA-1 interaction, the LFA-1 plays the most important role in signal transduction (13) (14) (15) (16) (17) . This signaling pathway through LFA-1 involves calcium mobilization, phosphoinositide hydrolysis, amplification of CD3-dependent IL-2 production, and proliferation and enhancing antigen presentation in B cells. Whereas direct intracellular signaling pathways through LFA-1 have been extensively described, there are few data about transducing effects through ICAM-1 (18, 19) and ICAM-2 (20) . All these data suggested that the main functional role of both ICAM-1 and ICAM-2 was their binding with LFA-1 which triggered some tramduction signals that affected directly other stimulatory surface proteins, enhancing cell activation. If one considers the high homology of CD50 with ICAM-1 and ICAM-2, and the fact that little is known about the functional involvement of CD50 in cell activation it could easily be assumed that CDS0, like ICAM-1 and ICAM-2, would play only a secondary role in signal transduction. However, since its first description (3), the important differences, described above (cell distribution and cell induction, intracytoplasmic domain, phosphorylation by PKC stimulation), suggested that CD50 could play a more active role in signal transduction than ICAM-1 or ICAM-2.
To analyze the role of CD50 in immune interactions, the ability of anti-CD50 mAbs to transduce signals into Jurkat cells, a T-derived cell line, was studied. In this study, direct biochemical and cellular evidences are described showing that CD50 (ICAM-3) is a molecule capable of transducing signals across the plasma membrane of these cells. More precisely, our results show a direct relationship between two protein tyrosine kinases (FTKs), p56 kk and p59~ (two nonreceptor PTKs of the src family), and CD50 molecule, suggesting their involvement in the CD50 signaling pathway. These data contribute to a better understanding of CDS0 (ICAM-3) activation pathways and present CDS0 as a new costimnlatory molecule with a probable enhancing role in immune response.
Materials and Methods

Antibodies and CeULin~
The following murine mAb to human antigens were used at the indicated concentrations: 101-1132 (anti-CD50, IgG1) (6); 140-11 (anti-CD50, IgG2b) (6); 152-2Dll (anti-CD50, IgG1) 0); 143-14 (CD27, IgG2a) (21); RM3A5 (anti-CD54, IgG2a) (22) ; 72-5D3 (anti-CD45, IgG1) (23); Cris-7 (anti-CD3, IgG1) (23); 124-1I)1 (anti-CO7, IgG1) (24); 133-1G6 (IgM) (25) ; and nonhinding NS1 ascites as a control (IgG1). All antibodies were purified by protein A affinity chromatography. Second step polyclonal goat anti-mouse Ig (GAM) (affinity purified) was purchased from Tago, Inc. (Burlingame, CA). P-Tyr (Ab-1), anti-phosphotyrosine (P-Tyr) mAb was obtained from Oncogene Science, Inc. (Manhasset, NY). Rabbit polydonal antiserum to p56 ~ (26) and p59~ (27) were kindly provided by Dr. K. M. l~lmutter (University of Washington, Seattle, WA). The Jurkat T-derived lymphobhstoid cell line was obtained from the European Collection of Cultured Cell Lines (Salisbury, UK) and was maintained in culture in RPMI 1640 medium supplemented with 10% FCS.
[Ca2+]i Measurements. INDO 1-AM cell labeling was performed according to a standard protocol (28) . Briefly, Jurkat cells were washed twice in INDO 1 buffer A (I-IBSS medium with 10 mM Hepes, pH 7.0), counted, and resuspended at 5 x 106 cells/ml. The fluorescent Ca 2. indicator INDO 1-AM (Molecular Probes, Inc., Eugene, OK) was added to cell lines to 12.5 #M. After a 30-rain incubation at 37~ the same volume of INDO 1 buffer B (HBSS with 10 mM Hepes and 5% FCS, pH 7.4) was added and reincubated for 30 min at 37~ Then, cells were washed twice with INDO 1 buffer C (HBSS with 10 mM Hepes, 10 #M DNAase, and 5% FCS, pH 7.2), counted, and resuspended at 5 x 10 ~ cells/m1 at room temperature. Several minutes before the stimulation, cells were resuspended at 5 x 10 s cells/m1 in INDO 1 buffer C and maintained at 37~ Cells were incubated with the different mAb for 15 rain, and then washed twice. Cross-linking stimulation of mAbs was made with a second step polydonal GAM, during the analysis. In some experiments CaCI2 was omitted from the INDO 1 buffer C medium, and EGTA 100 #M added instead. After the complete response without extracellular Ca 2., 10 #M CaC12 was added to the medium. Both Genistein and Herhimycin A (both from Calbiochem, LaJolh, CA) were used as PTK inhibitots. In the experiments where Genistdn was used, this inhibitor was added 30 min before the analysis at 150, 75, 25, and 7.5 #M.
In the experiments where Herbimycin A was used, cells were preincubated with this PTK inhibitor 16 h before the assay. Both inhibitors were maintained throughout the assay. 
~2P-Orthophosphate Radiolabeling and P-Tyr lramunoprecipitation
Analysis. After washing twice in phosphate-free medium (20 mM /~Ci/rnl of [3ZP]orthophosphate (PBS 11; Amersham International). Radiolabding was carried out for 3 h in 6-well tissue culture plates (Costar Corp., Cambridge, MA) at 37~ in 5% CO2 according to a standard protocol (29) . Once labeled, ceils were incubated for 50 rnin with each mAb. Excess antibodies were removed by centrifugation and pellets were resuspended in 1 ml of medium with 25/~g/ml of GAM. Incubation was carried out for 5 min and then, cells were disrupted at 4~ for 30 mill in a lysis buffer containing protease and phosphatase inhibitors (30) . After four clearing cycles with an unrelated mAb plus protein A-Sepharose, supernatants were adjusted to contain identical acid-insoluble radioactivity and incubated for 1-2 h with 10/~1 of P-Tyr (Ab-1) anti-P-Tyr mAb. Then, lysates were incubated for 1-2 h with 50/~1 prorein A-Sepharose packed beads adsorbed with a rabbit anti-mouse Ig serum (Dako, Glostrup, Denmark). The resulting immune cornpieces were washed, eluted, and analyzed by SDS-PAGE (31) in 10% polyacrylamide slab gels at 30 mA/gel. The gel was dried and exposed to Kodak X-Omat AK films with intensifying screens at -80~ For assessing molecular masses, a standard 14C-labeled protein mixture (Amersham International) was inchded in the gels.
In Vitro Kinase Assay. Solubilization and kinase reactions were performed as previously described (32), with some modifications. Briefly, ceils were harvested and solubilized at 2 x 107 ceils/ml in either 1% Triton X-100 lysis buffer (1% Triton X-100/150 mM NaC1 with I mM sodium orthovanadate + 1 mM EDTA + leupeptin [10 mg/ml] + aprotinin [10 mg/ml] + 25 mM p-nitrophenyl-p-guanidinobenzoate) or in 1% digitonin lysis buffer (1% digitonin/150 mM NaC1/50 mM Hepes, pH 7.5, with the above inhibitors; digitonin was prepared as described by Oettgen et al. [33] ). Soluble lysates from 107 cells were incubated at 4~ for 1 h with different mAb and then, immunoprecipitated for 1 h with protein A-Sepharose (Pharmacia LKB, Uppsah, Sweden). After immunoprecipitation, immune complexes were washed in lysis buffer with appropriate detergent but without EDTA. In some cases, 1 M MgCh lysis buffer was used for washing out associated molecules (3). Immunocomplex kinase assays were performed by incubation at 4~ for 15 min in 50 t~l kinase buffer (150 mM NaCI + 20 mM Hepes, pH 7.5, + 5 mM MnClz + 5 mM MgC12 + 1 mM ATP + 10 mCi of 3"-[32P]ATP). The reaction was stopped with lysis buffer containing the appropriate detergent and 20 mM F_DTA. Immunocomplezes were washed twice in lysis buffer, ehted in SDS sample buffer and analyzed by SDS-PAGE 8% (30) .
Phosphoamino Acid Anal)sis. 3~P-labded proteins were electroeluted from excised bands of polyacrylamide gels, precipitated with cold acetone/NH3 (5.3:0.3) and hydrolyzed in 0.2 ml 6 M HC1 at 110~ for 2 h. Acid-hydrolyzed samples were dried, resuspended in 0.2 ral HzO, and dried again. The residue was then resuspended in 10 /~1 in electrophoresis buffer (pyridine/acetic acid/water, 5:50:945), pH 3.5. Samples of 2-10/~1 were spotted on cellulosecoated plates (E. Merck, Darmstadt, Germany), next to 1/~1 of a phosphoamino acid standard solution (phosphoserine, phosphothreonine, and phosphotyrosine, milligram per milliliter each), and analyzed by one-dimensional thin-layer electrophoresis (1000 V, 45 rain). Nonradioactive standards were detected with 0.25% ninhydrin in ethanol and radiolabeiled phosphorylated amino acids by autoradiography.
CD50 lmmunoFrecipitation and PTK (Western) Blot Analysis.
To control the eCficiency of immunoprecipitation, we previously labeled cells with 12sI. For this radiolabeling, Jurkat cells were surface-labeled with 12sI using Iodogen (Pierce Chemical Co., Rockford, IL) (34) . After labeling, 2 x 107 Jurkat cells were lysed in 1 ml lysis buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaC1, 1 mM EDTA, 1 mM EGTA, 0.5% NP-40, I raM NaF, I mM PMSF, 20/tl/ml egg white trypsin inhibitor, 1/tg/ml leupeptin, and 1 /~g/ml pepstatin) for 30 min on ice. Nuclei and insoluble debris were removed by centrifugation at 14,000g for 10 min and lysates precleared with protein A-Sepharose (Pharmacia LKK Uppsah, Sweden), prewashed in lysis buffer. Immunoprecipitation was performed with the indicated mAb, coupled to CNBr-activated Sepharose CI~4B (Pharw~_~_' _~_ LKB) for I h at 4~ washed six times with washing buffer (50 mM Tris-HCl, 150 mM NaC1, 5 mM EHEA, pH 8.0, 0.05% NP-40, 0.05% SDS, and with the above iuln~itors) and duted with 2x SDS reducing sample buffer. Samples were counted with a 3' counter. The same quantity ofcpm for each sample was loaded in each lane and samples were run on 8% SDS-PAGE 01), and transferred by electroblotting (4 mA/cm 2) with glycine transfer buffer (39 mM glycine, 48 mM Tris-base, 1.3 mM SDS, and 20% methanol) to nitrocellulose. SDS-PAGE molecular weight standards (Bio-Rad Laboratories, Richmond, CA) were used. After incubating filters with blocking solution (5% ovalbumin [Sigma Chemical Co., St. Louis, MO] and 3% nonfat milk protein in PBS) overnight at 4~ blots were incubated with anti-p56 ~ and anti-p59~ diluted to 1:1,000 in blocking solution for 1 h at 20~ After washing with 0.25% gehtin in PBS, filters were incubated with goat anti-rabbit coupled to peroxidase in blocking solution for 1 h at 20~ Filters were washed again with 0.25% gelatin in PBS, and the Western blots were developed using Amersham's enhanced chemiluminescence (ECL) reagent (Amersham International). mAb has always been identical or lower than the one observed with the 152-2Dll mAb. . A singular characteristic of the effect obtained with the CD50 mAb was the fact that although the maximum effect of CD50 cross-linking took longer to be reached than the one obtained by CD3 mAb, the increase of [Ca2+]i observed using CDS0 mAbs reached a higher and more sustained plateau than the plateau obtained with CD3 mAb: CD50 effect reached its maximum level at 100-120 s after stimulation (70-100 s with CD3), but it was maintained at a high plateau (higher than CD3 stimulation) for longer than 500 s. Dose-response experiments were performed using different concentratiom of anti-CD50 mAb (Fig. 2 A) and cross-linking antibody (Fig. 2 B) . The transient increase [Ca2+]i was shown to be proportional to the amount of anti-CD50 mAb. A minimum effect was observed with a dose as low as 2/~g/ml and the maximum level was reached with oversaturating amounts of mAbs (100/~g/ml) (Fig. 2 A) . Regarding the cross-linking antiserum, the relative increase in [Ca 2 + ]i was proportional to the concentration used, reaching its highest level with oversaturating (50/~g/ml) amounts of GAM (Fig.  2 B) . Taking all these data into account, the doses of 50/~g/ml of 152-2Dll and 10/~g/ml of GAM, which were shown to be dearly stimulating, were chosen as standard doses for all subsequent assays.
Results
CD50 (ICAM-3) Cross-linking Induces a Transient Increase in Intracellular Calcium
Simultaneous CD3 and CD50 (ICAM-3)
Cross-flnleing; Involveraent of Different Ca 2+ Sources. When Jurkat cells were treated simultaneously with stimulating concentrations of both CD3 and CD50 mAb, plus GAM, a high increase in [Ca2+]i was observed (Fig. 3 A) . The increase in [Ca2+]i was sharper than the one observed when CD3 or CD50 mAbs were used alone, whereas the peak of [Ca2+]i reached under these conditions was similar to the addition of the effects of anti-CD50 and anti-CD3 used separately. Moreover, the increase in [Ca 2+ ]i using both mAbs simultaneously was prolonged on a level higher than the one obtained using CD3 or CD50 mAb alone. Therefore, the response to both mAb seems to be the addition of each separated response, resulting in a global improvement of the [Ca2+]i signaling.
To better characterize the mechanisms responsible for the effect of anti-CD50 mAb, Ca 2 + mobilization in Jurkat cells was analyzed in Ca 2+-free, EGTA-containing medium before and after the CaCI2 addition (Fig. 3 B) . Under Ca 2+-free conditions, a rapid increase could be observed as a result of Ca 2 + redistribution from intraceUular stores; however, this effect was shorter and smaller than the increase observed in medium with Ca 2+ . The characteristic sustained phteau that is observed stimulating with CD50 mAb and which is higher than the level obtained upon CD3 stimulation, disappeared using Ca2+-free conditions. Subsequent addition (Fig. 3 B, arrow) of Ca 2 + to the medium (10 p2Vl CaCh) induced a further [Ca2+]i increase, as a result of the uptake of extracellular Ca 2+. This increase achieved a plateau as high as the one obtained using the medium with Ca 2+ . AU these data suggest that the increase in Ca 2 § obtained by anti-CDS0 stimulation is mainly due to the uptake of extracellular Ca 2 +. This extracellular Ca 2 § would be responsible for the characteristic prolongation of the increase, whereby the Ca 2* from the internal stores would be responsible only for the initial increase, and even in this case in a minor way.
To analyze the role of inositol phospholipid hydrolysis in CD50 Ca 2+ mobilization, the II)3 levels on stimulated Jurkat cells were evaluated. After CD50 stimulation with 152-2Dll cross-linking, a slight but clear increase of IP3 at 15 s (Table  1 ) was detected; IP3 increase induced by CD50 mAb was lower than the increase induced by CD3 mAb used as positive control. No IP3 increase was observed by using GAM alone (negative control). Thus, the effect of CDS0 stimulation on IP3 levels correlated perfectly with the initial induction of Ca 2 + mobilization. This correlation could probably explain the intracellular component of Ca 2+ increase.
Ca 2+ Mobilization Induced by CD50 (ICAM-3) Cross-linking Is Mediated by Tyrosine Phosphorflation.
To further analyze the signal transduction pathway responsible for the effect of CDS0 mAb, the role of tyrosine phosphorylation on the increase in [Ca2+]i (Fig. 4) was studied. Pretreatment of Jurkat ceils for 30 min and throughout the assay with 7.5, 25, 75, and 150 #M of Genistein showed an inhibitory effect on Ca z+ mobilization. This inhibition was partial at 7.5, 25, and 75/~M and almost total at 150/~M (Fig. 4 A) . Instead, the stimulatory effect of CD3 was only partially inhibited by Genistein (data not shown), blunting the Ca z+ increase, as previously described (35) . Furthermore, pretreatment of Jurkat cells for 16 h with Herbimycin A at 1 #M also completely prevented the increase in [Ca2*]i induced by CDS0 mAbs (Hg. 4 B). As previously described (36) , Herbimycin A also totally inhibited CD3 Ca z + mobilization, although an increase in [Ca2+]i induced by A23187 ionophore was completely resistant to both Genistein and Herbiraycin A (data not shown).
For a better understanding of the role of PTK in Ca z+ mobilization induced by CDS0 mAb, the effect of CD45 on this effect was analyzed. A mAb against CD45, which is a molecule with phosphatase activity (37), was incubated simultaneously with CDS0 mAb. A total inhibition on the CD50 Ca z+ increase was observed with the co-cross-linking of CDS0 and CD45 mAb (Hg. 4 C). These data are in agreement with similar observations where phosphatase activity of CD45 was shown to inhibit analogous Ca 2+ mobilizations dependent on kinase activity (38, 39) .
CDSO (ICAM.3) Cross.hieing Induces TFosine.Phospl~flation of 33-and 40-leD-specific Substrates. The effects of both, PTK
inhibitors and CD45 on CDS0 induced Ca 2+ mobilization made us analyze the pattern of tyrosine phosphorylation after CDS0 cross-1/nking, l~2-1abeled Jurkat cells (Fig. 5) were treated with CD50 mAb (152-2Dll) and cross-linked with GAM for 5 min. After immunoprecipitation with an anti-PTyr mAb of the lysates, a remarkable increase in the tyrosine phosphoryhtion pattern was observed. Especially rdevant was the effect on a 33-kD molecule that appeared phosphorylated after CD3 and CD50 stimulation and was absent in the negative control. In addition, a significant increase in the phosphorylation ofa 40-kD protein after CD50 cross-linking was also detected.
CD50 (ICAM-3) mAb Coimmunoprecipitates an Associated
Tyrosine Kinase Activit2,: both p5# ~ and p59~ PTK Are Detected in Association with CD50. The immunoprecipitate obtained with the three CD50 mAb were tested in an in vitro kinase assay. Fig. 6 A shows the pattern of phosphorylation obtained when 1% Triton X-100 was used as detergent. A specific phosphoryhtion of a 31-kD molecule was observed, confirming the presence of a kinase activity associated with the CD50 molecule, contrasting with the lack of phosphorylation after immunopredpitating with a negative control mAb (anti-CD27). In addition, we had previously shown that washing in 1 M MgC12 is able to diminate all the associated molecules without ehting CD50 molecule from the mAb binding (3). The results in Fig. 6 A show that the kinase activity was duted by using 1 M MgC12 washing buffer, suggesting that this kinase activity was not intrinsically due to the CDS0 molecuh. To assess the type of phosphorylation, the 31-kD phosphorylated protein was hydrolyzed and subjected to phosphoamino add anaiysis which showed a phosphoryhtion on tyrosine residues (Fig. 6 B) . To further confirm these results, an in vitro kinase assay with 1% digitonin buffer was performed. This procedure produced a stronger and more complex pattern of phosphorylation, which also included the 31-kD molecule. The kinase activity was also washed out by using 1 M MgC12 solution (Fig. 6 C) , thus confirming the previous observation. Negative controls with mAb against unrelated Jurkat molecules (CD7 and CD27) did not show any kinase activity. Among the phosphorylated proteins there were two phosphoryhted molecules whose molecular masses suggested that they could correspond to the previously described PTK, p56 ~, and p59~. Generally both PTK become autophosphoryhted (32, 40) in in vitro kinase assays, and those labeled bands on the digitonin pattern could correspond to them. To better characterize the tyrosine kinase-associated activity and to confirm the presence of lck and/or fyn PTK, the immunoprecipitates were tested by Western blotting analysis with anti-lck and anti-fyn rabbit antisera. Fig. 7 shows that CD50 mAb coimmanoprecipitated both a 56-kD lck protein and a 59-kD fyn PTK.
Discu~don
Identified as ICAM-3, an adhesion molecule involved in the initiation of immune responses, the role of CD50 seems restricted to being a new counter-receptor of LFA-1, a main molecule in leukocyte interactions (1, 2) . In spite of the resemblances to the other ICAMS, important CD50 differences (cell distribution, cell inductions, intracytoplasmic domain, phosphorylation by PKC stimulation) lead us to suggest a different role for this molecule, probably through its intracytoplasmic domain.
In this paper, data are presented showing that an ICAM molecule, CD50 (ICAM-3), is able to transduce signals in a T cell line. One of the most outstanding characteristics of this signal transduction is the Ca 2+ mobilization. Assays using CD50 and CD3 mAb eross-linking (Fig. 1) allowed us to compare both signaling pathways. The most striking difference is that the CD50 mAb produces a slower, blunter, and steadier increase of Ca 2 + than the CD3 mAb. From the data shown in Pig. 3 B, it comes out that both CD3 and CDS0 mAb mobilize Ca 2+ from both sources, that is, internal stores and extracellular input; however, it seems that the extracellular Ca 2 § mobilization, through CD50 mAb stimulation, is more intense and prolonged than the release of intracellular stores. Moreover, the effect of simultaneous stimulation with CD3 and CD50 mAbs (Pig. 3 A) showed an increase of [Ca2+]i that was more complex than the simple addition of each individual stimulation. These two sets of data, analysis of the Ca 2+ sources and costimulation with CD3 and CDS0 mAb, suggest that both stimulating molecules involve both, a common as well as a different signal transduction pathway.
Regarding the factors that regulate Ca 2+ mobilization, from the results presented in this paper, it appears that both IPo metabolism and phosphorylation are playing a role. Taking into consideration both, the IPo increase and the Ca 2+ mobilization from the internal stores, it appears that the low participation of the intracellular stores could be associated with the low levels of IP3 observed after CD50 cross-linking. Furthermore, the complete blockade of Ca 2+ uptake in the presence ofPTK inhibitors (Herbimycin A and Genistein), suggests that a PTK activity could be associated with CD50. In addition, in vitro kinase assays of CD50 immunoprecipitates showed the presence ofa kinase activity associated with CD50 rather than inherent in the CD50 molecule. Moreover, a PTK stimulation was also responsible for a very important increase of the tyrosine phosphorylation of several substrates including a 33-and a 40-kD proteins. This 40-kD protein could be the equivalent to the substrate observed after CD2 and CD3 stimulation (41) . Finally, the Western blot analysis with specific antisera against two wellcharacterized FFKs, p56 kk, and p59~, suggest that both kinases could be involved in CDS0 signaling processes. This double association could explain two phosphorylated bands present in the phosphorylation pattern of in vitro kinase assays developed in digitonin detergent conditions. As was previously described, fyn and lck PTKs generally become antophosphorylated upon activation (32, 40) . Thus, their presence, on an immunoprecipitation, is detected as phosphoryhted molecules when a in vitro kinase assay is performed (Fig. 4 C, arrows). Although a defined membrane molecule has usually been associated exclusively with one of the two FIXs, the simultaneous association of both kinases has also been described with TCR-CD3 (42), CD55, a phosphatidylinositol [inked membrane protein (43) , and also recently with CD2 (44) . These data raise the question about the different roles played by p56 ta and p59~. However, taking into account the differential expression of these PTKs on the hematopoietic ceUs, a different PTK association of CD50 on the different hematopoietic lineages could easily be assumed. In this context, the broad distribution of CD50 molecuh could imply a different functional rule of CD50 in each kind of cell.
How CD50 interacts with both PTKs is one of the most interesting aspects to be analyzed. In the absence of experimental data, we could assume that the intracytoplasmic domain is responsible for CD50 binding with both PTKs. The interaction between CDS0 and the different PTKs could be regnlated through CDS0 serine phosphorylations, in a similar way as the one that has been described for CD4 molecnle. CD4, like CD50, presents three phosphorylated serine residues when T cells are activated by antigen or phorbol esters (45) . These serines are placed next to the p56 ~k recognition site in the CD4 molecule (46) . However, the characteristic cysteine motif (46) of lck-CD4/CD8 interaction is not present in CD50. Likewise, an indirect association of CD50 with a muhimolecular complex formed by the antigen receptor, CD4 or CDS, HLA, CD2, and CD5 (47) could not be ruled out. Moreover, we have observed that when CD50 mAb are co-cross-linked with CD45 mAb, the functional effects of CD50 are abrogated (Fig. 4 C) . That means that the function of the CD50-assodated PTKs seems to be regulated by CD45 phosphatase.
It is important to point out that the CD50 signal transduction capacity, described in this paper (Ca 2 + mobilization or PTK activity induction), is dearly observed by using both 101-1D2 and 152-2Dll mAbs. These two mAbs recognize two different CD50 epitopes not related to LFA-1 binding (3). In contrast, the mAb 140-11, which recognizes an epitope critical for LFA-1 binding (3), has been shown to be unable to transduce signals in the assays used in this study. In any case, all three CD50 mAbs used were able to coimmunoprecipitate FTK activity as well as p56 l~k and p59~. Taking into account that certain differences in the affinities of the mAb have been observed (152-2D11>101-1D2>140-11) (Juan, M., unpublished observation), these differences could be responsible for their different activation capability. However, all these data could also be interpreted by considering that the induction of conformational changes produced by 101-1D2 and 152-2Dll mAbs on CD50 molecule are necessary to induce intraceUular signaling. A similar situation has been previously described with other differentiation antigens such as CD2 (48) and CD45 (49) , where, depending on the epitope recognized, a different functioml effect was observed.
It should also be noted that the transduction of signals could be a bidirectional process, where the binding of CDS0 to its counter-receptor, LFA-1, would trigger both molecules to send intracellular signals that would help in the cell activation process. It has also been observed that CD50 crosslinking induced CD25 expression and IL-2 production after PMA stimulation (Juan, M., M. K. Pino-Otfn, and E. Martfnez-C~ceres, unpublished data). Furthermore, experiments carried out recently in our laboratory, concerning the role of CD50 in lymphocyte-endothdium adhesion and homotypic aggregation (50) showed that CDS0 stimulation is able to enhance B1 and B2 integrin function in T lymphocytes. These data, together with the data described in this paper, strongly suggest that CDS0 (ICAM-3) is not only a counterreceptor for LFA-1, but it is also by itself a functionally relevant signaling molecule.
